Articles and resources
Examination of False Positives in Fetal cfDNA Analysis
OZ Systems joins Revvity
SMA Europe launches whitepaper
Implications of Fetal Fraction measurement variability in NIPS – Webinar & Transcript
Clinical Validation of Fetal cfDNA Analysis Using Rolling-Circle-Replication and Imaging Technology in Osaka (CRITO Study)
Understanding Fetal Fraction in cfDNA screening
Evaluation of repeat testing of a non-sequencing based NIPT test on a Finnish general-risk population
Products may not be licensed in accordance with the laws in all countries, such as the United States, Canada. Please check with your local representative for availability.
Revvity does not endorse or make recommendations with respect to research, medication, or treatments. All information presented is for informational purposes only and is not intended as medical advice. For country specific recommendations please consult your local health care professionals.